We have observed
16 EP applications
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after July 17, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
METHOD FOR INCREASING THE REPLICATION CAPACITY OF AN INFLUENZA VIRUS IN CULTURED CELLS
METHODS AND PHARMACEUTICAL COMPOSITIONS FOR INHIBITING INFLUENZA VIRUSES REPLICATION
KATP ANTAGONISTS (GLIBENGLAMID) FOR USE FOR PROMOTING GROWTH AND/OR TREATING HYPERGLYCAEMIA OF A PREMATURE INFANT
ATTENUATED PLASMODIUM WITH THE HMGB2 GENE INACTIVATED AS A VACCINE
METHODS AND A DEVICE FOR THE FORMATION OF THREE-DIMENSIONAL MULTICELLULAR ASSEMBLIES
INGREDIENTS FOR ANIMAL FEED COMPOSITIONS
BACTERIA AND THE USES THEREOF
COMPOSITIONS AND METHODS FOR THE TREATMENT OF RETINAL DEGENERATION
LIQUID FORMULATIONS OF HYPOGLYCAEMIC SULPHONAMIDES
FOOD COMPOSITIONS FOR STIMULATING THE FORMATION OF BONE TISSUE
Analogues of temporin-SHa and uses thereof
METHOD FOR DIAGNOSING AND DIFFERENTIATING HIV-2 INFECTIONS
PROCESS FOR CULTURING DEINOCOCCUS BACTERIA
CLUSTER OF DIFFERENTIATION 36 (CD36) AS A THERAPEUTIC TARGET FOR HIV INFECTION
Skin whitening peptide agents
Polymorphisms predictive of pancreatic cancer